Magnetic Resonance Imaging Versus Computed Tomography Guidance for Stereotactic Body Radiotherapy in Prostate Cancer: 2-year Outcomes from the MIRAGE Randomized Clinical Trial.

Autor: Kishan AU; Department of Radiation Oncology, University of California-Los Angeles, Los Angeles, CA, USA; Department of Urology, University of California-Los Angeles, Los Angeles, CA, USA. Electronic address: aukishan@mednet.ucla.edu., Lamb JM; Department of Radiation Oncology, University of California-Los Angeles, Los Angeles, CA, USA., Wilhalme H; Statistics Core, Department of Medicine, University of California-Los Angeles, Los Angeles, CA, USA., Casado M; Department of Radiation Oncology, University of California-Los Angeles, Los Angeles, CA, USA., Chong N; Department of Radiation Oncology, University of California-Los Angeles, Los Angeles, CA, USA., Zello L; Department of Radiation Oncology, University of California-Los Angeles, Los Angeles, CA, USA., Juarez JE; Department of Radiation Oncology, University of California-Los Angeles, Los Angeles, CA, USA., Jiang T; Department of Radiation Oncology, University of California-Los Angeles, Los Angeles, CA, USA., Neilsen BK; Department of Radiation Oncology, University of California-Los Angeles, Los Angeles, CA, USA., Low DA; Department of Radiation Oncology, University of California-Los Angeles, Los Angeles, CA, USA., Yang Y; Department of Radiation Oncology, University of California-Los Angeles, Los Angeles, CA, USA., Neylon J; Department of Radiation Oncology, University of California-Los Angeles, Los Angeles, CA, USA., Basehart V; Department of Radiation Oncology, University of California-Los Angeles, Los Angeles, CA, USA., Martin Ma T; Department of Radiation Oncology, University of Washington, Seattle, WA, USA., Valle LF; Department of Radiation Oncology, University of California-Los Angeles, Los Angeles, CA, USA; Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, CA, USA., Cao M; Department of Radiation Oncology, University of California-Los Angeles, Los Angeles, CA, USA., Steinberg ML; Department of Radiation Oncology, University of California-Los Angeles, Los Angeles, CA, USA.

Publikováno v: European urology [Eur Urol] 2024 Nov 12. Date of Electronic Publication: 2024 Nov 12.

Biochemical Recurrence Surrogacy for Clinical Outcomes After Radiotherapy for Adenocarcinoma of the Prostate.

Autor: Roy S; Department of Radiation Oncology, Rush University Medical Center, Chicago, IL., Romero T; Department of Medicine Statistics Core, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA., Michalski JM; Department of Radiation Oncology, Washington University, St Louis, MO., Feng FY; Department of Radiation Oncology, University of California San Francisco, San Francisco, CA., Efstathiou JA; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA., Lawton CAF; Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI., Bolla M; Radiotherapy Department, University Hospital, Grenoble, France., Maingon P; Department of Oncology, Hematology, and Supportive Care, Sorbonne University, Paris, France., de Reijke T; Department of Urology, Prostate Cancer Network in the Netherlands, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands., Joseph D; Department of Medicine and Surgery, University of Western Australia, Perth, WA, Australia., Ong WL; Alfred Health Radiation Oncology, Monash University, Melbourne, VIC, Australia., Sydes MR; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, United Kingdom., Dearnaley DP; Division of Radiotherapy and Imaging, The Institute of Cancer Research and Department of Urology, The Royal Marsden NHS Foundation Trust, London, United Kingdom., Tree AC; Department of Radiation Oncology, University of Washington, Seattle, WA., Carrier N; Clinical Research Center, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, QC, Canada., Nabid A; Department of Radiation Oncology, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, QC, Canada., Souhami L; Department of Radiation Oncology, McGill University Health Centre, Montréal, QC, Canada., Incrocci L; Department of Radiation Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Heemsbergen WD; Department of Radiation Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Pos FJ; Department of Radiation Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., Zapatero A; Hospital Universitario de la Princesa, Madrid, Spain., Guerrero A; Hospital Son Espases, Palma de Mallorca, Spain., Alvarez A; Hospital General Universitario Gregorio Marañón, Madrid, Spain., San-Segundo CG; Hospital General Universitario Gregorio Marañón, Madrid, Spain., Maldonado X; Hospital Universitari Vall d'Hebron, Barcelona, Spain., Reiter RE; Department of Urology, University of California Los Angeles, Los Angeles, CA., Rettig MB; Department of Medical Oncology, University of California Los Angeles, Los Angeles, CA., Nickols NG; Department of Radiation Oncology, University of California Los Angeles, Los Angeles, CA., Steinberg ML; Department of Radiation Oncology, University of California Los Angeles, Los Angeles, CA., Valle LF; Department of Radiation Oncology, University of California Los Angeles, Los Angeles, CA., Ma TM; Department of Radiation Oncology, University of Washington, Seattle, WA., Farrell MJ; Department of Radiation Oncology, University of California Los Angeles, Los Angeles, CA., Neilsen BK; Department of Radiation Oncology, University of California Los Angeles, Los Angeles, CA., Juarez JE; Department of Radiation Oncology, University of California Los Angeles, Los Angeles, CA., Deng J; Department of Radiation Oncology, University of California Los Angeles, Los Angeles, CA., Vangala S; Department of Medicine Statistics Core, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA., Avril N; Department of Radiology, Division of Nuclear Medicine, Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH., Jia AY; Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH., Zaorsky NG; Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH., Sun Y; Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH.; Department of Population Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH., Spratt D; Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH., Kishan AU; Department of Radiation Oncology, University of California Los Angeles, Los Angeles, CA.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Nov 10; Vol. 41 (32), pp. 5005-5014. Date of Electronic Publication: 2023 Aug 28.

Radiation therapy dose and androgen deprivation therapy in localized prostate cancer: a meta-regression of 5-year outcomes in phase III randomized controlled trials.

Autor: Jiang T; Department of Radiation Oncology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.; Department of Urology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA., Markovic D; Department of Medicine, Statistics Core, University of California, Los Angeles, CA, USA., Patel J; Department of Radiation Oncology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA., Juarez JE; Department of Radiation Oncology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA., Ma TM; Department of Radiation Oncology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA., Shabsovich D; Department of Radiation Oncology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA., Nickols NG; Department of Radiation Oncology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA., Reiter RE; Department of Urology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA., Elashoff D; Department of Medicine, Statistics Core, University of California, Los Angeles, CA, USA., Rettig MB; Division of Hematology and Oncology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.; Division of Hematology and Oncology, VA Greater Los Angeles Healthcare System, Los Angeles, CA, USA., Zaorsky NG; Department of Radiation Oncology, Penn State Cancer Institute, Hershey, PA, USA., Spratt DE; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA., Kishan AU; Department of Radiation Oncology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA. aukishan@mednet.ucla.edu.; Department of Urology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA. aukishan@mednet.ucla.edu.

Publikováno v: Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2022 Mar; Vol. 25 (1), pp. 126-128. Date of Electronic Publication: 2021 Aug 16.

Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography-Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer.

Autor: Xiang M; Department of Radiation Oncology, University of California, Los Angeles., Ma TM; Department of Radiation Oncology, University of California, Los Angeles., Savjani R; Department of Radiation Oncology, University of California, Los Angeles., Pollom EL; Department of Radiation Oncology, Stanford University, Stanford, California., Karnes RJ; Department of Urology, Mayo Clinic, Rochester, Minnesota., Grogan T; Department of Medicine Statistics Core, David Geffen School of Medicine at UCLA, Los Angeles, California., Wong JK; Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Motterle G; Department of Urology, Mayo Clinic, Rochester, Minnesota., Tosoian JJ; Department of Urology, University of Michigan, Ann Arbor., Trock BJ; Department of Urology, Brady Urological Institute, Johns Hopkins University, Baltimore, Maryland., Klein EA; Department of Urology, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio., Stish BJ; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota., Dess RT; Department of Radiation Oncology, University of Michigan, Ann Arbor., Spratt DE; Department of Radiation Oncology, University of Michigan, Ann Arbor., Pilar A; Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada., Reddy C; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio., Levin-Epstein R; Department of Radiation Oncology, University of California, Los Angeles., Wedde TB; Department of Oncology, Oslo University Hospital, Norwegian Radium Hospital, Oslo, Norway., Lilleby WA; Department of Oncology, Oslo University Hospital, Norwegian Radium Hospital, Oslo, Norway., Fiano R; Schiffler Cancer Center, Wheeling Hospital, Wheeling Jesuit University, Wheeling, West Virginia., Merrick GS; Schiffler Cancer Center, Wheeling Hospital, Wheeling Jesuit University, Wheeling, West Virginia., Stock RG; Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York City, New York., Demanes DJ; Department of Radiation Oncology, University of California, Los Angeles., Moran BJ; Prostate Cancer Foundation of Chicago, Westmont, Illinois., Huland H; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg Eppendorf, Hamburg, Germany., Tran PT; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland., Martin S; Department of Oncology, Clínica Universitaria de Navarra, University of Navarra, Pamplona, Spain., Martinez-Monge R; Department of Oncology, Clínica Universitaria de Navarra, University of Navarra, Pamplona, Spain., Krauss DJ; Oakland University William Beaumont School of Medicine, Royal Oak, Michigan., Abu-Isa EI; Department of Radiation Oncology, University of Michigan, Ann Arbor., Alam R; Department of Urology, Brady Urological Institute, Johns Hopkins University, Baltimore, Maryland., Schwen Z; Department of Urology, Brady Urological Institute, Johns Hopkins University, Baltimore, Maryland., Pisansky TM; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota., Choo CR; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota., Song DY; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland., Greco S; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland., Deville C; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland., McNutt T; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland., DeWeese TL; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland., Ross AE; Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, Illinois., Ciezki JP; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio., Boutros PC; Department of Human Genetics, University of California, Los Angeles., Nickols NG; Department of Radiation Oncology, University of California, Los Angeles.; Department of Radiation Oncology, Veterans Affairs (VA) Greater Los Angeles Healthcare System, Los Angeles, California., Bhat P; Department of Radiation Oncology, University of California, Los Angeles., Shabsovich D; Department of Radiation Oncology, University of California, Los Angeles., Juarez JE; Department of Radiation Oncology, University of California, Los Angeles., Chong N; Department of Radiation Oncology, University of California, Los Angeles., Kupelian PA; Department of Radiation Oncology, University of California, Los Angeles., Rettig MB; Division of Hematology and Oncology, Department of Medicine, University of California, Los Angeles.; Department of Hematology and Oncology, Veterans Affairs (VA) Greater Los Angeles Healthcare System, Los Angeles, California., Zaorsky NG; Department of Radiation Oncology, Penn State Cancer Institute, Hershey, Pennsylvania., Berlin A; Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada., Tward JD; Department of Radiation Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City., Davis BJ; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota., Reiter RE; Department of Urology, University of California, Los Angeles., Steinberg ML; Department of Radiation Oncology, University of California, Los Angeles., Elashoff D; Department of Medicine Statistics Core, David Geffen School of Medicine at UCLA, Los Angeles, California., Horwitz EM; Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Tendulkar RD; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio., Tilki D; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg Eppendorf, Hamburg, Germany.; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany., Czernin J; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA Medical Center, Los Angeles, California., Gafita A; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA Medical Center, Los Angeles, California., Romero T; Department of Medicine Statistics Core, David Geffen School of Medicine at UCLA, Los Angeles, California., Calais J; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA Medical Center, Los Angeles, California., Kishan AU; Department of Radiation Oncology, University of California, Los Angeles.

Publikováno v: JAMA network open [JAMA Netw Open] 2021 Dec 01; Vol. 4 (12), pp. e2138550. Date of Electronic Publication: 2021 Dec 01.

Patterns of Clinical Progression in Radiorecurrent High-risk Prostate Cancer.

Autor: Philipson RG; Department of Radiation Oncology, University of California Los Angeles, Los Angeles, CA, USA., Romero T; UCLA Division of General Internal Medicine and Health Services Research, Los Angeles, CA, USA., Wong JK; Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA., Stish BJ; Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA., Dess RT; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA., Spratt DE; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA., Pilar A; Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Canada; Department of Radiation Oncology, University of Toronto, Toronto, Canada., Reddy C; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Wedde TB; Oslo University Hospital, Oslo, Norway., Lilleby WA; Oslo University Hospital, Oslo, Norway., Fiano R; Schiffler Cancer Center, Wheeling Hospital, Wheeling Jesuit University, Wheeling, WV, USA., Merrick GS; Schiffler Cancer Center, Wheeling Hospital, Wheeling Jesuit University, Wheeling, WV, USA., Stock RG; Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Demanes DJ; California Endocurietherapy Cancer Center, Oakland, CA, USA., Moran BJ; Chicago Prostate Cancer Center, Westmont, IL, USA., Braccioforte M; Chicago Prostate Cancer Center, Westmont, IL, USA., Tran PT; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Martin S; Department of Radiation Oncology, Clínica Universidad de Navarra and Program in Solid Tumors, CIMA- University of Navarra, Pamplona, Spain., Martinez-Monge R; Department of Radiation Oncology, Clínica Universidad de Navarra and Program in Solid Tumors, CIMA- University of Navarra, Pamplona, Spain., Krauss DJ; Oakland University William Beaumont School of Medicine, Royal Oak, MI, USA., Abu-Isa EI; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA., Valle L; Department of Radiation Oncology, University of California Los Angeles, Los Angeles, CA, USA., Chong N; Department of Radiation Oncology, University of California Los Angeles, Los Angeles, CA, USA., Pisansky TM; Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA., Choo CR; Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA., Song DY; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Greco S; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Deville C; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA., McNutt T; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA., DeWeese TL; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Ross AE; Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Ciezki JP; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Tilki D; Department of Urology and Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany., Karnes RJ; Department of Urology, Mayo Clinic, Rochester, MN, USA., Klein EA; Department of Urology, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA., Tosoian JJ; Department of Urology, The James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Boutros PC; Department of Urology, University of California Los Angeles, Los Angeles, CA, USA., Nickols NG; Department of Radiation Oncology, University of California Los Angeles, Los Angeles, CA, USA; Department of Radiation Oncology, West Los Angeles Veterans Health Administration, Los Angeles, CA, USA., Bhat P; David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA., Shabsovich D; David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA., Juarez JE; David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA., Kupelian PA; Department of Radiation Oncology, University of California Los Angeles, Los Angeles, CA, USA., Rettig MB; Department of Medical Oncology, University of California Los Angeles, Los Angeles, CA, USA; Department of Medical Oncology, West Los Angeles Veterans Health Administration, Los Angeles, CA, USA., Berlin A; Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Canada., Tward JD; Department of Radiotherapy Oncology, Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT, USA., Davis BJ; Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA., Reiter RE; Department of Urology, University of California Los Angeles, Los Angeles, CA, USA., Steinberg ML; Department of Radiation Oncology, University of California Los Angeles, Los Angeles, CA, USA., Elashoff D; UCLA Division of General Internal Medicine and Health Services Research, Los Angeles, CA, USA., Horwitz EM; Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA., Tendulkar RD; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Kishan AU; Department of Radiation Oncology, University of California Los Angeles, Los Angeles, CA, USA; Department of Urology, University of California Los Angeles, Los Angeles, CA, USA. Electronic address: aukishan@mednet.ucla.edu.

Publikováno v: European urology [Eur Urol] 2021 Aug; Vol. 80 (2), pp. 142-146. Date of Electronic Publication: 2021 May 10.